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Abstract
Background: Functional antagonism between transforming growth factor beta (TGF-β ) and
hyaluronidase has been demonstrated. For example, testicular hyaluronidase PH-20 counteracts
TGF-β 1-mediated growth inhibition of epithelial cells. PH-20 sensitizes various cancer cells to
tumor necrosis factor (TNF) cytotoxicity by upregulating proapoptotic p53 and WW domain-
containing oxidoreductase (WOX1). TGF-β 1 blocks PH-20-increased TNF cytotoxicity. In the
present study, the functional antagonism between TGF-β 1 and lysosomal hyaluronidases Hyal-1
and Hyal-2 was examined.
Results: Murine L929 fibroblasts were engineered to stably express green-fluorescent protein
(GFP)-tagged hyaluronidase (GFP-Hyal-1 or GFP-Hyal-2) or GFP alone. Compared to control cells,
Hyal-2-expressing cells had a significantly increased sensitivity to TNF cytotoxicity (~60–110%
increase), while Hyal-1-expressing cells were less sensitive to TNF (~20–90% increase). TNF
activated NF-κ B, along with Iκ Bα  degradation, occurred at 20 to 60 min in Hyal-2 cells post
stimulation, but at the 20 min time point in both control and Hyal-1 cells. Hyal-2 cells, but not Hyal-
1 and control cells, constitutively expressed WOX1, and transiently expressed Hyal-2 enhanced
WOX1-mediated cell death. Unlike PH-20, Hyal-1 and Hyal-2 did not induce p53 expression. Hyal-
2 translocated from the lysosome to the mitochondria during staurosporine-mediated apoptosis,
suggesting that Hyal-2 may damage mitochondria. Finally, Hyal-1 and Hyal-2 blocked TGF-β 1-
enhanced L929 cell growth. In contrast, TGF-β 1 inhibited Hyal-1- and Hyal-2-increased TNF
cytotoxicity in L929 cells by 30–50%.
Conclusions: TGF-β 1 limits the ability of Hyal-2 to induce TNF cytotoxicity in L929 cells. Hyal-2-
increased TNF cytotoxicity in L929 cells appears to be correlated with upregulation of WOX1, a
prolonged NF-κ B activation, and Hyal-2 translocation to the mitochondria during apoptosis.
Background
Transforming growth factor beta (TGF-β ) family proteins
are multifunctional cytokines capable of regulating cell
growth, extracellular matrix protein synthesis, and im-
mune cell functions [1,2]. Hyaluronidase is an extracellu-
lar matrix-degrading enzyme. Interestingly, malignant
and metastatic breast and prostate cancer cells frequently
overexpress both hyaluronidase and TGF-β  proteins [3–
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7]. Previously we have shown that bovine testicular hy-
aluronidase, also known as PH-20, increases the suscepti-
bility of various cancer cells to tumor necrosis factor (TNF
or TNF-α ) cytotoxicity [[8], review]. PH-20 induces the ex-
pression of proapoptotic p53 [9] and WOX1 (WW do-
main-containing oxidoreductase; also known as WWOX
or FOR) [10], which contributes to the increased TNF cy-
totoxic effect. PH-20-induced downregulation of the ex-
tracellular matrix inter-α -inhibitor is also associated with
the enhanced TNF cytotoxicity [9].
TGF-β  family proteins, including β 1,β 2 and β 3, induce
TNF-resistance and suppress the PH-20 effect of increasing
TNF cytotoxicity in murine L929 fibroblasts [8,11]. TGF-
β 1 induces a novel extracellular matrix protein that pre-
vents TNF-mediated cell death and blocks the activation
of extracellular signal-regulated kinase (ERK; also known
as p42/44 mitogen-activated protein kinase, p42/44
MAPK) in L929 cells [8,12]. Additionally, TGF-β 1 induces
the expression of TIAF1 (TGF-β -induced antiapoptotic
factor) [13] and TIF2 (TGF-β -induced factor 2) [14] that
inhibit TNF cytotoxicity. Whether these TGF-β 1-induced
proteins restrict the ability of PH-20 to increase TNF cyto-
toxicity is unknown.
PH-20 blocks TGF-β 1-mediated growth suppression of
epithelial cells [8,15]. Additionally, PH-20 rapidly acti-
vates ERK in L929 cells and TGF-β 1 reduces the PH-20-in-
duced ERK activation [16]. In contrast, TGF-β 1
synergistically increases PH-20-mediated inhibition of
staurosporine apoptosis [16]. Thus, PH-20 and TGF-β 1
are physiological antagonists for only certain cellular re-
sponses.
Hyaluronidases Hyal-1 and Hyal-2 play a critical role in
cancer invasion and metastasis [3–5], although inactiva-
tion of HYAL1 gene has been shown in head and neck sq-
uamous cell carcinomas [17]. Hyal-1, also known as Luca-
1, is a lysosomal enzyme that is secreted from cells. Hyal-
1 is a candidate tumor suppressor [5,18], although it en-
hances extravasation and metastasis of prostate cancer
cells [3]. Also, mutations in Hyal-1 may contribute to the
pathogenesis of a lysosomal disorder, mucopolysacchari-
dosis IX [19]. Hyal-2 is a lysosomal protein, which is ac-
tive at low pH [20]. This protein is also known to be a
glycosylphosphatidylinositol (GPI)-anchored cell-surface
receptor for jaagsiekte sheep retrovirus [21].
Testicular hyaluronidase PH-20 counteracts TGF-β 1-in-
duced TNF-resistance in L929 cells [8]. The goal of the
present study was to examine whether lysosomal Hyal-1
and Hyal-2 enhance TNF cytotoxic function and counter-
act TGF-β 1-mediated TNF-resistance in L929 cells. It was
determined that stable expression of murine Hyal-2 in
L929 cells increased their sensitivity to TNF-mediated
death, whereas Hyal-1 was somewhat less effective. TGF-
β 1 blocked this increased sensitivity. In contrast, Hyal-1
and Hyal-2 did not enhance L929 cell death by anticancer
drugs such as daunorubicin, actinomycin D, stau-
rosporine and camptothecin. Overexpressed Hyal-1 and
Hyal-2 induced the expression of proapoptotic WOX1,
but not p53, suggesting a role of WOX1 in the increased
cellular susceptibility to TNF cytotoxicity. Additional
mechanisms that are associated with the increased TNF cy-
totoxicity were also investigated.
Results
As summarized in Figure 1, PH-20 induces the expression
of proapoptotic p53 and WOX1 [9,10] and downregulates
antiapoptotic matrix inter-α -inhibitor [9], thereby en-
hancing TNF susceptibility in L929 cells. Also, PH-20 rap-
idly activates ERK and c-Jun N-terminal kinase (JNK1 and
JNK2) [16]. Whether these signaling events lead to induc-
tion of p53 and WOX1 is unknown.
In contrast, TGF-β 1 protects L929 cells from TNF cytotox-
icity by upregulating the expression of antiapoptotic
TIAF1, TIF2 and a novel matrix protein [11–14]. TGF-β 1
blocks PH-20-increased TNF susceptibility [15]. Likewise,
Figure 1
Proposed basis for the antagonistic actions of PH-20 and
TGF-β 1 on L929 cell susceptibility to TNF cytotoxicity. Tes-
ticular hyaluronidase PH-20 enhances TNF cytotoxicity in
L929 fibroblasts (see green), whereas TGF-β 1 induces TNF-
resistance in these cells (see red). Both upregulation of proa-
poptotic p53 and WOX1 and downregulation of antiapop-
totic matrix inter-α -inhibitor are involved in the PH-20-
increased TNF susceptibility in L929 cells [8–10]. Also, PH-
20 rapidly activates ERK (or p42/44 MAPK) and c-Jun N-ter-
minal kinases (JNK1 and JNK2) [16]. In contrast, TGF-β 1
protects L929 cells from TNF cytotoxicity by upregulating
antiapoptotic TIAF1, TIF2 and a novel matrix protein [11–
14]. TGF-β 1 counteracts PH-20-induced TNF-susceptibility
in L929 cells [8]. TGF-β 1 suppresses PH-20-mediated ERK
activation [16], whereas ERK activation is not related with
PH-20-increased TNF susceptibility in L929 cells [15].
Whether the proapoptotic p53 and WOX1 block the antiap-
optotic function of TIAF1 and TIF2 is not known.
Hyaluronidase PH-20
Increased sensitivity
to TNF cytotoxicity
L929
Fibroblasts 1. Activation of ERK, JNK1 and JNK2;
2. Upregulation of p53 and WOX1;
3. Downregulation of inter-α  inhibitor.
 TGF-β 1
1. Induction of antiapoptotic TIAF1, TIF2
    and a novel matrix protein;
2. Inhibition of PH-20-mediated ERK
    activation.
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PH-20 inhibits TGF-β 1-induced TNF-resistance [15]. TGF-
β 1 suppresses PH-20-mediated ERK activation [16]; how-
ever, the ERK activation is not related with PH-20-in-
creased TNF susceptibility in L929 cells [15]. Whether the
proapoptotic p53 and WOX1 block the function of antia-
poptotic TIAF1 and TIF2 is not known. In this study, ex-
periments were designed to determine whether lysosomal
Hyal-1 and Hyal-2 enhance TNF cytotoxic function and
counteract TGF-β 1-mediated TNF-resistance in L929 cells.
The full-length murine hyaluronidase Hyal1 and Hyal2
cDNAs were found in the EST database (GenBank acces-
sion AA688635 and BF139787, respectively) and the de-
termined DNA sequences have been deposited in the
GenBank (Hyal1, AF422176; Hyal2, AF422177). The
Hyal1 cDNA encodes a 463-amino-acid protein, which
has 99.1% identity to a reported murine sequence
(AF011567) [18]. Differences in the protein sequences are
Gly-247, Gly-284 and Cys-450 in our Hyal-1 protein,
compared to Arg-247, Glu-284 and Arg-450 in AF011567.
Transitions in these amino acid residues are non-conserv-
ative.
The murine Hyal2 cDNA (AF422177) encodes a 473-ami-
no-acid protein. The deduced protein sequence is identi-
cal to a reported murine sequence (AF302844), but has an
Ile-355 to Val-355 transition compared to another clone
(AF302843). Variation in the protein sequence is also
found in a murine Hyal-2 homologue (NP_034619) [22],
which possesses three unique 2-, 5- and 7-amino-acid seg-
ments, not identical to the above Hyal-2 proteins.
L929 cells were engineered to stably express GFP-Hyal-1
or GFP-Hyal-2 fusion proteins. The presence of these pro-
teins in these cells was demonstrated in Western blotting
using anti-GFP antibody (data not shown). Exogenous
bovine testicular hyaluronidase PH-20 stimulates rapid
activation of c-Jun N-terminal kinases (JNK1 and JNK2) in
L929 cells [16]. In contrast, the stably expressed Hyal-1
and Hyal-2 could not mediate constitutive activation of
JNK1 and JNK2 in L929 cells (data not shown).
Exposure of the Hyal-2-expressing L929 cells to TNF for
16–24 hr resulted in increased cell death by ~60–110%,
compared to the control GFP-expressing cells (Fig. 2).
These results are similar to the bovine testicular PH-20-in-
creased TNF cytotoxicity of L929 cells [15]. In contrast,
there were no significant differences in the extent of cell
death when GFP-Hyal-2 and control GFP-expressing cells
were exposed to staurosporine, actinomycin D, daunoru-
bicin, or camptothecin for 16–24 hr (Fig. 2).
There was also an increased susceptibility to TNF cytotox-
icity in the Hyal-1-expressing L929 cells (approximately
20–90% increase; also see Fig. 7), compared to the GFP
control cells. However, there were no significant differenc-
es among these cells in the extent of death caused by stau-
rosporine, actinomycin D, daunorubicin and
camptothecin (data not shown).
In similar experiments, the effect of transient expression
of Hyal-1 and Hyal-2 on cellular sensitivity to anticancer
drugs was examined. L929 cells were electroporated with
the GFP-Hyal-1 or GFP-Hyal-2 construct, cultured for 48
hr and then exposed to actinomycin D, daunorubicin or
Figure 2
Hyal-2 increases L929 cell sensitivity to TNF cytotoxicity.
L929 cell lines that stably expressed GFP and GFP-Hyal-2
were established (see Materials and Methods) and exposed
to TNF-α , staurosporine, actinomycin D (ActD), daunoru-
bicin, or camptothecin for 24 hr. The extent of cell death
were measured by staining the cells with crystal violet as pre-
viously described (mean ± standard deviation; n = 8) [10].
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camptothecin for 24 hr. There were no differences in cell
death in these Hyal-1 and Hyal-2-expressing cells, com-
pared to control cells (data not shown). These findings are
consistent with the results for stable transfectants present-
ed above (Fig. 2).
Bovine testicular PH-20 enhances TNF sensitivity in L929
cells by increasing the expression of proapoptotic p53 and
WOX1 [9,10]. The ability of Hyal-1 and Hyal-2 to induce
the expression of p53 and WOX1 in L929 cells was exam-
ined. L929 cells were electroporated with nothing (null),
GFP, GFP-Hyal-1 or GFP-Hyal-2 constructs and cultured
for 48 hr. Transient expression of GFP-Hyal-1 or GFP-
Hyal-2 in L929 cells induced WOX1 expression, whereas
no WOX1 expression was observed in non-transfected
cells or control GFP-expressing cells (Fig. 3A). The 46-kDa
band is full-length WOX1, while the 31-kDa band is a de-
graded WOX1 [10]. No detectable p53 expression was ob-
served in these cells (Fig. 3A).
In comparison, the cytosolic WOX1 (46 kDa) was consti-
tutively expressed in the L929 cells stably transfected with
the GFP-Hyal-2 construct, while TNF reduced WOX1 ex-
pression in a time-dependent manner (Fig. 3B). This re-
duction is probably due to TNF-mediated WOX1 nuclear
translocation from the mitochondria [10]. In contrast,
WOX1 was not expressed in L929 cells stably transfected
with the GFP-Hyal-1 construct, and TNF induced WOX1
expression in 40 min (Fig. 3B). TNF did not induce WOX1
expression in the control GFP-expressing cells (Fig. 3B).
Whether Hyal-2 enhances the apoptosis-inducing func-
tion of WOX1 was determined. In transient transfection
experiments, L929 cells were electroporated with GFP-
Hyal-2 and/or WOX1 constructs. GFP-Hyal-2 enhanced
WOX1-mediated L929 cell death, as determined 48 hr
post-transfection using crystal violet staining (Fig. 3C). In
contrast, GFP-Hyal-1 did not enhance WOX1-mediated
cell death (Fig. 3C). GFP-Hyal-1 and GFP-Hyal-2 alone
did not mediate cell death (Fig. 3C).
Next, the effect of TNF-mediated Iκ Bα  degradation and
NF-κ B activation was examined in both Hyal-1 and Hyal-
2 cells. The GFP-Hyal-1 and GFP-Hyal-2 stable transfect-
ants and control cells were exposed to TNF for various
times. Iκ Bα  degradation and NF-κ B activation (or NF-κ B
nuclear translocation) were observed at 20 to 60 min in
Hyal-2 cells post TNF stimulation, but at the 20 min time
point in both control and Hyal-1 cells (Fig. 4).
To further understand how Hyal-2 participates in the ap-
optosis pathway, the translocation of Hyal-2 to the mito-
chondria was examined during cell death. Transient
expression of GFP-Hyal-2 in COS7 fibroblasts showed the
localization of the expressed protein in the lysosome but
not in the mitochondria, as determined by staining the
cells using LysoTracker and Mitotracker Red (data not
shown). These observations are consistent with other re-
ports [5,20]. COS7 cells are TNF-resistant. The reasons for
using this cell type are its large size (which provides better
resolution under fluorescence microscopy) and the ease
Figure 3
Hyal-2 induces WOX1 expression in L929 cells. (A) L929
cells were electroporated with nothing (null), GFP, GFP-
Hyal-1 or GFP-Hyal-2 construct (30 g DNA / 3 ×  106 cells)
and cultured for 48 hr. Transient expression of GFP-Hyal-1
and GFP-Hyal-2 in L929 cells induced WOX1 expression (46
and 31 kDa), whereas no WOX1 expression was observed
in non-transfected cells or control GFP-expressing cells. The
46-kDa band is full-length WOX1, and the 31-kDa band is a
degraded WOX1 [10]. No detectable p53 expression was
observed in these cells. α -Tubulin was examined to confirm
equal protein loading onto each lane of the gel. (B) In com-
parison, the GFP-Hyal-2 stable transfectant constitutively
expressed cytosolic WOX1 (46 kDa) and TNF (50 ng/ml)
reduced the WOX1 expression. The reduction is probably
due to TNF-mediated WOX1 nuclear translocation from the
mitochondria [10]. In contrast, WOX1 was not expressed in
the stable GFP-Hyal-1 cells, and TNF induced the expression
of WOX1 in a time-related manner. TNF could not induce
WOX1 expression in the control GFP-expressing cells. (C)
L929 cells were transfected with GFP-Hyal-2 and/or WOX1
constructs by electroporation. GFP-Hyal-2 enhanced
WOX1-mediated L929 cell death, as determined 48 hr post-
transfection using crystal violet staining (two representative
rows of cell stains shown at left and the analyzed data shown
at right; mean ± standard deviation, n = 4). cell death. In con-
trols, GFP-Hyal-1 or GFP-Hyal-2 alone failed to induce cell
death.
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of transfection and gene expression using liposome-based
reagents such as FuGene 6 and GeneFector. Exposure of
the GFP-Hyal-2-expressing COS7 cells to staurosporine
(for inducing apoptosis) resulted in a time-related in-
crease in co-localization of GFP-Hyal-2 with the mito-
chondria (Fig. 5), suggesting that a portion of GFP-Hyal-2
migrates to the mitochondria during apoptosis.
Next, whether TGF-β 1 antagonizes the function of Hyal-1
and Hyal-2 in growth regulation was examined. TGF-β 1
inhibits epithelial cell growth but promotes fibroblast
growth [15]. TGF-β 1 inhibition of epithelial cell growth is
blocked by bovine testicular PH-20 [15]. In agreement
with our previous observations [11], TGF-β 1 promoted
L929 cell growth by approximately 20% in 24–48 hr (Fig.
6). However, TGF-β 1 did not promote the growth of L929
cells stably expressing Hyal-1 or Hyal-2 (Fig. 6).
Finally, the functional antagonism between TGF-β 1 and
Hyal-1 or Hyal-2 in regulating TNF susceptibility in L929
cells was examined. The Hyal-1 and Hyal-2 stable trans-
fectants were pretreated with TGF-β 1 for 1 hr and then
treated with TNF overnight. Both Hyal-1- and Hyal-2-in-
creased TNF cytotoxicity were suppressed by TGF-β 1 (30–
50%) (Fig. 7). However, TGF-β 1 blocked TNF cytotoxicity
of the GFP-expressing control cells to a greater extent (50–
70%) (Fig. 7).
Discussion
In this study, the novel function of the lysosomal hyaluro-
nidases Hyal-1 and Hyal-2 in increasing cellular sensitivi-
ty to TNF cytotoxicity is reported. TGF-β 1 counteracted
Hyal-1- and Hyal-2-increased TNF killing of L929 fibrob-
lasts. TGF-β 1 increased L929 growth, while Hyal-1 and
Hyal-2 blocked this enhancement of cell growth. These
observations are consistent with our previous finding that
exogenous bovine testicular hyaluronidase PH-20 en-
hances TNF cytotoxicity in various cancer cells, and that
TGF-β 1 blocks the increased TNF cytotoxicity [8,15]. As
summarized in the Figure 8, the underlying mechanisms
whereby Hyal-2 induces TNF cytotoxicity appear to be as-
sociated with 1) Hyal-2 induction of the proapoptotic
WOX1, 2) Hyal-2 migration to the mitochondria during
apoptosis, and 3) the prolonged period of Iκ Bα  degrada-
tion and NF-κ B activation in TNF-treated Hyal-2-express-
ing cells.
Upregulation of p53 and WOX1 contributes, in part, to
the PH-20-enhanced cytotoxic function of TNF [9,10,23].
WOX1 is a p53-binding protein. Ectopic expression of
both p53 and WOX1 cDNA constructs results in colocali-
zation of these proteins in the mitochondria [23]. In-
creased synthesis and complex formation between p53
and WOX1 in the cytoplasm are observed during apopto-
Figure 4
TNF mediates a prolonged period of Iκ Bα  degradation and
NF-κ B activation in L929 cells stably expressing GFP-Hyal-2.
The GFP-Hyal-1 and GFP-Hyal-2 stable transfectants, as well
as control L929 cells, were exposed to TNF (50 ng/ml) for 0,
20, 40, 60 and 120 min, followed by analysis of protein
expression by Western blotting. TNF mediated a prolonged
cytosolic Iκ Bα  degradation, as well as a nuclear presence of
NF-κ B p65 (or NF-κ B activation), over a 20 to 60 min time
period in Hyal-2 cells. A similar effect was seen only at 20
min in Hyal-1 and control cells.
TNF-α 0   20   40   60   120   min
Control
Hyal-1
Hyal-2
Iκ Bα
Control
Hyal-1
Hyal-2
NF-κ B p65
(nuclear)
Figure 5
Migration of Hyal-2 to the mitochondria during stau-
rosporine-mediated apoptosis. COS7 cells were transfected
with the GFP-Hyal-2 construct using FuGene 6 (Roche) or
GeneFector (Venn Nova). The cells were cultured for 24–48
hr and then treated with staurosporine (stauro). Mitochon-
dria (Mito) were stained with Mitotracker Red and nuclei
were stained with DAPI. Co-localization analysis showed that
there was a time-related increase in co-localization of GFP-
Hyal-2 with mitochondria (see merged), suggesting that a
portion of GFP-Hyal-2 migrates to the mitochondria during
apoptosis. The nuclear stain is shown at the 2- and 4-hr time
points only.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/8
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sis [23]. Both p53 and WOX1 mediate apoptosis synergis-
tically. Overexpressed WOX1 alone mediates apoptosis
independently of p53 [10]. However, p53 apoptosis re-
quires the participation of WOX1. Blocking WOX1 expres-
sion with antisense mRNA abolishes p53-mediated cell
death, suggesting that WOX1 is a potential partner of p53
in apoptosis [10,23].
Both Hyal-1 and Hyal-2 induced WOX1 expression when
transiently expressed in L929 cells. However, only Hyal-2
induced WOX1 expression following stable transfection
of L929 cells. This correlates with the greater extent of
Hyal-2 enhancement of TNF killing compared to Hyal-1.
WOX1 expression was induced by TNF in the Hyal-1 sta-
ble transfectant. In transient transfection experiments,
Hyal-2 enhanced WOX1-mediated L929 cell death, while
Hyal-1 had no effect. Both Hyal-1 and Hyal-2 alone failed
to induce cell death. Thus, induction of WOX1 expression
contributes, in part, to Hyal-1- and Hyal-2-increased TNF
sensitivity in L929 cells.
TNF rapidly induces phosphorylation of Iκ Bα , which nor-
mally peaks at 5–10 min, followed by proteasome-de-
pendent degradation (10–20 min) [10,24]. Iκ Bα
degradation and NF-κ B activation occurred, as deter-
Figure 6
TGF-β 1 promotes L929 cell growth but not the growth of
Hyal-1 and Hyal-2-expressing L929 cells. Non-transfected
L929 cells or the stable GFP-Hyal-1 and GFP-Hyal-2-express-
ing cells were treated with TGF-β 1 (2 ng/ml) for 24 hr. The
extent of cell growth was measured by staining the cells with
crystal violet (mean ± standard deviation; n = 8).
Figure 7
TGF-β 1 suppresses Hyal-1 and Hyal-2-increased TNF cyto-
toxicity in L929 cells. L929 cells stably expressing GFP, GFP-
Hyal-1 or GFP-Hyal-2 were cultured in 96-well plates over-
night, treated with TGF-β 1 (2 ng/ml) for 2 hr, and then
cotreated with TNF-α  (5–40 ng/ml) for 24 hr. TGF-β 1 inhib-
ited TNF-α  killing of L929 cells expressing GFP, and GFP-
Hyal-1 or GFP-Hyal-2 (mean ± β 1 inhibited TNF-α  killing of
the control GFP L929 cells to a greater extent (50–70%) than
the GFP-Hyal-1 or GFP-Hyal-2 cells (30–50%).
Figure 8
A summarized scheme for Hyal-2-induced TNF susceptibility
in L929 cells. Upregulation of proapoptotic WOX1 but not
p53 was observed in the Hyal-2-expressing cells. Unlike PH-
20, Hyal-2 could not induce constitutive JNK activation. TNF
cytotoxicity was enhanced in these Hyal-2-expressing cells.
The enhancement of TNF function is likely due to 1) the
induced proapoptotic WOX1, 2) the likely translocation of
Hyal-2 to the mitochondria in response to TNF, and 3) the
prolonged period of Iκ Bα  degradation and NF-κ B activation
in as mediated by TNF.
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mined 20 min after exposure of control and Hyal-1 cells
to TNF. However, there was an extended period of TNF-
mediated Iκ Bα  degradation and NF-κ B activation in Hyal-
2 cells, ranging from 20–60 min. It is unclear whether this
extend ed period of Iκ Bα  degradation and NF-κ B activa-
tion directly contributes to the ability of Hyal-2 to en-
hance TNF-mediated apoptosis. Iκ Bα  is a physiological
inhibitor of NF-κ B activation; Iκ Bα  complexes with NF-κ B
and prevents its translocation to the nucleus [10,24]. NF-
κ B activation is believed to induce antiapoptotic proteins
to block cell death [8]. However, in several studies activat-
ed NF-κ B cannot protect cells from apoptosis [8]. Also,
NF-κ B appears to be essential in the p53-mediated apop-
tosis in tested cell lines [25].
The mitochondrion is a reservoir of proapoptotic proteins
and plays a key role in apoptosis [[26,27]; reviews]. One
of the pathways that leads to the release of proapoptotic
proteins in the mitochondria has been determined. For
example, the TNF/TNF receptor-signaling complex acti-
vates caspase 8, which leads to the activation and cleavage
of Bid, a proapoptotic protein of the Bcl-2 family. Activat-
ed or truncated Bid (tBid) in turn activates Bak and Bax.
Bak migrates to the mitochondrial outer membrane where
it generates transmembrane pores; Bax induces the open-
ing of the mitochondrial permeability transition pores.
Cytochrome c is then released from the mitochondria into
the cytosol, where it interacts with downstream proapop-
totic proteins such as Apaf-1 and caspase 9. Activation of
these proteins further activates nucleases, such as caspase-
activated DNase (CAD), which cause DNA fragmentation.
During staurosporine-mediated apoptosis, a portion of
the lysosomal Hyal-2 migrates to the mitochondria.
Whether Hyal-2 causes mitochondrial membrane damage
is unknown. Presumably, Hyal-2 interacts with a specific
protein target on the mitochondrial surface that changes
the membrane permeability. This notion is supported by
our recent screening of Hyal-1 and Hyal-2 interacting pro-
teins in yeast two-hybrid interactions (Chang et al, unpub-
lished)
The functional property of Hyal-2 in degrading hyaluron-
ic acid is controversial. Hyal-2 is found in the lysosome
and is active under conditions of low pH [20]. Hyal-2 is
also found on the cell surface as a glycosylphosphatidyli-
nositol (GPI)-anchored receptor for jaagsiekte sheep ret-
rovirus [21]. Nonetheless, the enzymatic activity of Hyal-
2 has not been detected [21]. Whether the increased TNF
cytotoxicity in L929 cells caused by Hyal-1 and Hyal-2 is
associated with their enzymatic activities is being studied
in this laboratory.
The TGF-β 1 inhibition of Hyal-1 and Hyal-2 effects could
be abolished by cycloheximide or actinomycin D (data
not shown). That is, inhibition of protein synthesis or
gene transcription reduced the inhibitory effect of TGF-β 1
in the prevention of Hyal-1- or Hyal-2-increased TNF cy-
totoxicity. Whether TGF-β 1-induced antiapoptotic pro-
teins such as TIAF1 and TIF2 inhibit the function of Hyal-
1 and Hyal-2 remains to be determined.
Conclusions
Like testicular PH-20, lysosomal Hyal-1 and Hyal-2 en-
hanced TNF susceptibility in L929 cells. TGF-β 1 sup-
pressed the induced TNF sensitivity. Furthermore, TGF-
β 1-mediated L929 cell proliferation was blocked by Hyal-
1 and Hyal-2. These data indicate that there is a functional
antagonism between TGF-β 1 and Hyal-1 or Hyal-2. Hyal-
2-increased TNF susceptibility in L929 cells appears to be
associated with 1) Hyal-2 upregulation of the proapoptot-
ic WOX1, 2) Hyal-2 migration to the mitochondria during
apoptotic cell death, and 3) the prolonged Iκ Bα  degrada-
tion and NF-κ B activation in Hyal-2-expressing cells stim-
ulated with TNF.
Materials and Methods
cDNA constructs, transient expression and stable trans-
fectants
The full-length murine hyaluronidase Hyal1 and Hyal2
cDNAs were found in the EST database (Genbank acces-
sion AA688635 and BF139787, respectively) and pur-
c h a s e d  f r o m  I n c y t e  G e n o m i c s  ( S t .  L o u i s ,  M O ) .  T h e
determined DNA sequences have been deposited in the
GenBank (Hyal1, AF422176; Hyal2, AF422177). The cod-
ing regions were tagged with a C-terminal green fluores-
cent protein (GFP) sequence by subcloning into the EcoR1
site of the pEGFP-N1 vector (Clontech, Palo Alto, CA).
Murine L929 cells were transfected with the constructed
Hyal-1-pEGFP-N1 or Hyal-2-pEGFP-N1 vector, or a con-
trol pEGFP-N1 vector by electroporation (40 µg DNA/ 5 ×
106 cells; 250 volt and 960 Fd), as previously described
[10]. The cells were cultured in the continuous presence of
G418 (200 g/ml) for approximately 2 weeks, and the re-
sulting total cell colonies were harvested. The presence of
GFP-Hyal-1 and GFP-Hyal-2 proteins in these stable trans-
fectants was examined by Western blotting using anti-GFP
antibodies (Clontech). Where indicated, COS7 fibroblasts
were transfected with the above constructs using a lipo-
some-based reagent FuGene 6 (Roche, Indianapolis, IN)
or GeneFector (Venn Nova, Pompano Beach, FL). Protein
expression was visualized by fluorescence microscopy. Al-
so, the cells were counterstained with LysoTracker or Mi-
totracker Red (Molecular Probes, Eugene, OR) to
determine whether the expressed protein was located in
the lysosome or mitochondria.
Cell lines and chemicals
Murine L929 fibroblasts and monkey kidney COS7 fi-
broblasts were cultured as previously described [10]. Stau-BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/8
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rosporine, daunorubicin, actinomycin D, camptothecin
and DAPI were from Calbiochem (San Diego, CA), Sigma
(St. Louis, MO) and Biomol (Plymouth Meeting, PA). Pu-
rified human platelet TGF-β 1 was from R&D (Minneapo-
lis, MN). Antisera against WOX1 were generated in rabbits
against a synthetic peptide [10]. Antibodies against p53,
Iκ Bα , NF-κ B p65 and α -tubulin were from Santa Cruz Bi-
otechnology (Santa Cruz, CA) and Accurate Chemicals
(Accurate Chemical, Westbury, NY).
TNF cytotoxicity assay and Western blotting
The above established cell lines were treated with TNF-α
(2.5–20 ng/ml; Pepro-Tech, Rocky Hill, NJ) for 16–24 hr.
The extent of cell death was determined by crystal violet
staining [10]. Where indicated, the cells were also exposed
to staurosporine, actinomycin D, daunorubicin, and
camptothecin for 16–24 hr, before determining the extent
of cell death. To determine whether TGF-β 1 blocked Hyal-
1 and Hyal-2-increased TNF killing, the cells were pre-
treated with TGF-β 1 for 2 hr and then exposed to TNF-α
in the continued presence of TGF-β 1 for 16–24 hr. The ex-
tent of cell death was then determined. Where indicated,
GFP-Hyal-1, GFP-Hyal-2 and GFP stable transfectants
were treated with TNF (50 ng/ml) for 0, 20, 40, 60 and
120 minutes. The cells were extracted using NE-PER Nu-
clear and Cytoplasmic Extraction Reagents (Pierce, Rock-
ford, IL) to separate the cytoplasmic and nuclear fractions.
These preparations were subjected to SDS-PAGE and
Western blotting using specific antibodies against Iκ Bα ,
WOX1 and NF-κ B.
Gene transfection and fluorescent microscopy
COS7 cells were transfected with the GFP-Hyal-2 vector
using the liposome-based FuGene 6 or GeneFector, cul-
tured for 24–48 hr, and treated with staurosporine (1 M)
for 0, 1, 2 and 4 hr. Mitochondria were stained with the
membrane potential sensitive Mitotracker Red. Nuclei
were stained by DAPI. The cells were then examined by
fluorescence microscopy.
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